Humana execs sell $38M in shares

Humana’s top executives offloaded a significant sum of shares in late December, shedding about 107,077 Humana shares worth $37.7 million, Louisville Business First reported.

The selloff comes at a time when Humana’s share prices have been soaring, closing at a new all-time high of $365.88 on Dec. 16. Higher company earnings are matched with a rosy outlook for corporate tax cuts. In fact, 15 of Humana’s highest share price closings fell in November and December.

Humana CEO Bruce Broussard sold 62,700 shares for roughly $21.7 million, according to public filings.

Humana’s share prices, along with other major healthcare insurers, jumped on the news that a handful of Affordable Care Act taxes could be eliminated.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.